Current Neuropharmacology
Title:Meet Our Editorial Board Member
Volume: 17 Issue: 1
Author(s): Francesca Fallarino
Affiliation:
Export Options
About this article
Cite this article as:
Fallarino Francesca , Meet Our Editorial Board Member, Current Neuropharmacology 2019; 17 (1) . https://dx.doi.org/10.2174/1570159X1701181129110842
DOI https://dx.doi.org/10.2174/1570159X1701181129110842 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
19
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Soluble Forms of RAGE in Human Diseases: Clinical and Therapeutical Implications
Current Medicinal Chemistry Molecular Biology of the Enzymes that Degrade Endocannabinoids
Current Drug Targets - CNS & Neurological Disorders The Vasopressin V1b Receptor as a Therapeutic Target in Stress-related Disorders
Current Drug Targets - CNS & Neurological Disorders Neuropharmacological Actions of Metformin in Stroke
Current Neuropharmacology Graphical Abstracts:
Current Neuropharmacology Impact of Buprenorphine on Learning and Memory Ability, Oxidative Status and Inflammation in the Hippocampus of Rats
Current Molecular Pharmacology Using Mass Spectrometry-Based Peptidomics to understand the Brain and Disorders such as Parkinson’s Disease and Schizophrenia
Current Topics in Medicinal Chemistry Chemical Research and Evaluation of the Antioxidant Activity of the Flowers of Annona coriacea Mart. (Annonaceae)
Current Bioactive Compounds A Review of Clinical Trials of Belimumab in the Management of Systemic Lupus Erythematosus
Current Pharmaceutical Design Snake Venom: From Deadly Toxins to Life-saving Therapeutics
Current Medicinal Chemistry Immunotherapy for Prostate Cancer
Current Pharmaceutical Design Peripheral Biomarkers to Assess Suicide Risk
Current Psychiatry Reviews Influence of Phenobarbital on Morphine Metabolism and Disposition:LC-MS/MS Determination of Morphine (M) and Morphine-3-Glucuronide (M3G) in Wistar-Kyoto Rat Serum, Bile, and Urine
Current Drug Metabolism Metabolism and Pharmacological Mechanisms of Active Ingredients in <i>Erigeron breviscapus</i>
Current Drug Metabolism Two -Year Efficacy and Safety of Botulinum a Toxin Intravesical Injections in Patients Affected by Refractory Painful Bladder Syndrome
Current Drug Delivery Progress in the Development of Nonpeptidomimetic BACE 1 Inhibitors for Alzheimers Disease
Current Medicinal Chemistry The Role of Apoptotic Pathways in Alzheimers Disease Neurodegeneration and Cell Death
Current Alzheimer Research Rationale and First Results of Developing At-Risk (Prodromal) Criteria for Bipolar Disorder
Current Pharmaceutical Design Synthesis, Anticonvulsant and Binding Interaction Study of Novel Piperamides with Bovine Serum Albumin by Fluorescence Spectroscopy
Central Nervous System Agents in Medicinal Chemistry Anti-Cancer Cytotoxic Effects of Multiwalled Carbon Nanotubes
Current Pharmaceutical Design